To examine the hour-to-hour and day-to-day reproducibility of the CAV-test in young and older humans
ID
Source
Brief title
Condition
- Arteriosclerosis, stenosis, vascular insufficiency and necrosis
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The relative change in diameter during the CAV
Secondary outcome
N.A.
Background summary
Cardiovascular disease remains the world's leading cause of mortality and
morbidity. In the development of cardiovascular disease, the presence of
endothelial dysfunction plays a crucial step. It has been demonstrated that the
presence of endothelial dysfunction precedes the development of
artherosclerosis. Identification of the presence of endothelial dysfunction,
therefore, has important clinical implications.
A few years ago, the carotid artery vasoreactivity (CAV) test was introduced.
The CAV demonstrates distinct responses between healthy subjects and those with
cardiovascular risk. During the CAV-test, the carotid artery diameter response
is measured in response to a strong activation of the sympathetic nervous
system by putting a hand in a bucket of ice water. In analogy with coronary
arteries (but not peripheral arteries), this test causes a strong dilation of
the carotid artery (of ~10%) in healthy subjects. Interestingly, subjects with
cardiovascular risk factors or those with cardiovascular disease demonstrate a
small or even absent dilation, or even a constriction. The assumption is that
this simple, non-invasive test provides information about the endothelial
function and may possess prognostic value. However, currently little is known
about the reproducibility of this test in young or older humans. This
information is important to appropriately design future studies that adopt the
CAV.
Study objective
To examine the hour-to-hour and day-to-day reproducibility of the CAV-test in
young and older humans
Study design
Observational cohort study
Study burden and risks
Assessment of the CAV takes 5 minutes, which is preceded by a 20 minute resting
period. The CAV-test is non-invasive and associated with minimal burden.
Therefore, our experiments only places a minimal burden on the subjects, in
time as well as physically.
Philips van Leijdenlaan 15
Nijmegen 6525 EX
NL
Philips van Leijdenlaan 15
Nijmegen 6525 EX
NL
Listed location countries
Age
Inclusion criteria
-Younger subjec ts (18-30 years)
-Older subjects (>50 years)
-Mentally capable of providing informed consent
Exclusion criteria
- Increased risk coronary spasms
-Presence of Raynaud's phenomenon, chronic pain syndrom in extremities, presence of AV-fistel or shunt, open wounds and/or sklerodermia
-Recent (<3 months) presence of angina pectoris, myocardial infarction, stroke or heart failure
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL51166.091.14 |